Report Ocean presents a new report on subdermal contraceptive implants market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for ...
Vivani Medical, Inc. (NASDAQ:VANI), on Wednesday, released preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic weight management in obese and overweight ...
On Tuesday, Vivani Medical Inc (NASDAQ:VANI) announced the publication of positive proof-of-concept weight loss data with OKV-119 to treat feline obesity and diabetes in the peer-reviewed BMC ...
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a Phase 1 study evaluating the safety, tolerability and ...
NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing NPM-139 is a miniature, subdermal implant in development ...
Wirelessly rechargeable brain implants could make it easier for researchers to control individual neurons in rats using pulses of lights. Optogenetics is a research tool in neuroscience that uses ...
That’s based on the 2024 subdermal implant service fee of $93.41. Indiana’s Medicaid program reimbursed nearly 40,000 live births in 2022, according to the analysis, but a fraction of patients are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results